Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-124507
Filing Date
2023-04-28
Accepted
2023-04-28 08:28:58
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS d502404dars.pdf ARS 2514155
  Complete submission text file 0001193125-23-124507.txt   3464685
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36483 | Film No.: 23860501
SIC: 8071 Services-Medical Laboratories